CDC20 and cancer: Our results in Fig. 6 reveal that Mad2:Cdc20P, APC/CP:Cdc20, Cdc20, Cdc25, and ATM/ATR are more sensitive to parameter perturbations in p53-null cancer cell lines than in p53-wt cells.